Chordia Therapeutics Inc…announced that it has conﬁrmed that the ﬁrst patient has been dosed in the Initial Expansion Cohort of the ongoing Phase 1/2 clinical trial of rogocekib in the United States (hereinafter, the “Study”).

rogocekib (CTX-712) - Chordia Therap

Mar 18, 2026